Prospective multicentre cohort trial on acute appendicitis and microbiota, aetiology and effects of antimicrobial treatment: study protocol for the MAPPAC (Microbiology APPendicitis ACuta) trial

Sanja Vanhatalo, Eveliina Munukka, Suvi Sippola, Sirpa Jalkanen, Juha Grönroos, Harri Marttila, Erkki Eerola, Saija Hurme, Antti J Hakanen, Paulina Salminen, APPAC collaborative study group, V Sallinen, A Leppäniemi, T Rautio, S Meriläinen, P Nordström, J Laukkarinen, T Rantala, H Savolainen, M Aarnio, A Mattila, J Haijanen, E-L Sävelä, I Imre, H Paajanen, J Rintala, T Pinta, T Sippola, P Böckerman, Sanja Vanhatalo, Eveliina Munukka, Suvi Sippola, Sirpa Jalkanen, Juha Grönroos, Harri Marttila, Erkki Eerola, Saija Hurme, Antti J Hakanen, Paulina Salminen, APPAC collaborative study group, V Sallinen, A Leppäniemi, T Rautio, S Meriläinen, P Nordström, J Laukkarinen, T Rantala, H Savolainen, M Aarnio, A Mattila, J Haijanen, E-L Sävelä, I Imre, H Paajanen, J Rintala, T Pinta, T Sippola, P Böckerman

Abstract

Introduction: Based on the epidemiological and clinical data, acute appendicitis can present either as uncomplicated or complicated. The aetiology of these different appendicitis forms remains unknown. Antibiotic therapy has been shown to be safe, efficient and cost-effective for CT-confirmed uncomplicated acute appendicitis. Despite appendicitis being one of the most common surgical emergencies, there are very few reports on appendicitis aetiology and pathophysiology focusing on the differences between uncomplicated and complicated appendicitis. Microbiology APPendicitis ACuta (MAPPAC) trial aims to evaluate these microbiological and immunological aspects including immune response in the aetiology of these different forms also assessing both antibiotics non-responders and appendicitis recurrence. In addition, MAPPAC aims to determine antibiotic and placebo effects on gut microbiota composition and antimicrobial resistance.

Methods and analysis: MAPPAC is a prospective clinical trial with both single-centre and multicentre arm conducted in close synergy with concurrent trials APPendicitis ACuta II (APPAC II) (per oral (p.o.) vs intravenous+p.o. antibiotics, NCT03236961) and APPAC III (double-blind trial placebo vs antibiotics, NCT03234296) randomised clinical trials. Based on the enrolment for these trials, patients with CT-confirmed uncomplicated acute appendicitis are recruited also to the MAPPAC study. In addition to these conservatively treated randomised patients with uncomplicated acute appendicitis, MAPPAC will recruit patients with uncomplicated and complicated appendicitis undergoing appendectomy. Rectal and appendiceal swabs, appendicolith, faecal and serum samples, appendiceal biopsies and clinical data are collected during the hospital stay for microbiological and immunological analyses in both study arms with the longitudinal study arm collecting faecal samples also during follow-up up to 12 months after appendicitis treatment.

Ethics and dissemination: This study has been approved by the Ethics Committee of the Hospital District of Southwest Finland (Turku University Hospital, approval number ATMK:142/1800/2016) and the Finnish Medicines Agency. Results of the trial will be published in peer-reviewed journals.

Trial registration number: NCT03257423.

Keywords: antimicrobial resistance; appendectomy; appendicitis; appendicitisaetiology; appendicolith; microbiota.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
The synergy between MAPPAC, APPAC II and III studies. APPAC II, APPendicitis ACuta II; i.v, intravenous; MAPPAC, Microbiology APPendicitis ACuta; p.o., per oral.
Figure 2
Figure 2
Flow chart of the study protocol. APPAC II, APPendicitis ACuta II; i.v, intravenous; MAPPAC, Microbiology APPendicitis ACuta; p.o., per oral.

References

    1. Addiss DG, Shaffer N, Fowler BS, et al. . The epidemiology of appendicitis and appendectomy in the United States. Am J Epidemiol 1990;132:910–25. 10.1093/oxfordjournals.aje.a115734
    1. Ferris M, Quan S, Kaplan BS, et al. . The global incidence of appendicitis: a systematic review of population-based studies. Ann Surg 2017;266:237–41. 10.1097/SLA.0000000000002188
    1. Livingston EH, Fomby TB, Woodward WA, et al. . Epidemiological similarities between appendicitis and diverticulitis suggesting a common underlying pathogenesis. Arch Surg 2011;146:308–14. 10.1001/archsurg.2011.2
    1. Forbes GB, Lloyd-Davies RW. Calculous disease of the vermiform appendix. Gut 1966;7:583–92. 10.1136/gut.7.6.583
    1. Lamps LW. Infectious causes of appendicitis. Infect Dis Clin North Am 2010;24:995–1018. 10.1016/j.idc.2010.07.012
    1. Swidsinski A, Dörffel Y, Loening-Baucke V, et al. . Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum. Gut 2011;60:34–40. 10.1136/gut.2009.191320
    1. Zhong D, Brower-Sinning R, Firek B, et al. . Acute appendicitis in children is associated with an abundance of bacteria from the phylum Fusobacteria. J Pediatr Surg 2014;49:441–6. 10.1016/j.jpedsurg.2013.06.026
    1. Jindal N, Kaur GD, Arora S, et al. . Bacteriology of acute appendicitis with special reference to anaerobes. Indian J Pathol Microbiol 1994;37:299–305.
    1. Martirosian G, Bulanda M, Wójcik-Stojek B, et al. . Acute appendicitis: the role of enterotoxigenic strains of Bacteroides fragilis and Clostridium difficile. Med Sci Monit 2001;7:382–6.
    1. Chen C-Y, Chen Y-C, Pu H-N, et al. . Bacteriology of acute appendicitis and its implication for the use of prophylactic antibiotics. Surg Infect 2012;13:383–90. 10.1089/sur.2011.135
    1. Reinisch A, Malkomes P, Habbe N, et al. . Bad bacteria in acute appendicitis: rare but relevant. Int J Colorectal Dis 2017;32:1303–11. 10.1007/s00384-017-2862-0
    1. Guinane CM, Tadrous A, Fouhy F, et al. . Microbial composition of human appendices from patients following appendectomy. MBio 2013;4:12 10.1128/mBio.00366-12
    1. Peeters T, Penders J, Smeekens SP, et al. . The fecal and mucosal microbiome in acute appendicitis patients: an observational study. Future Microbiol 2019;14:111–27. 10.2217/fmb-2018-0203
    1. Bennion RS, Baron EJ, Thompson JE, et al. . The bacteriology of gangrenous and perforated appendicitis--revisited. Ann Surg 1990;211:165–71. 10.1097/00000658-199002000-00008
    1. Rivera-Chavez FA, Peters-Hybki DL, Barber RC, et al. . Innate immunity genes influence the severity of acute appendicitis. Ann Surg 2004;240:269–77. 10.1097/01.sla.0000133184.10676.26
    1. Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A 2011;108 Suppl 1:4554–61. 10.1073/pnas.1000087107
    1. Jernberg C, Löfmark S, Edlund C, et al. . Long-Term ecological impacts of antibiotic administration on the human intestinal microbiota. Isme J 2007;1:56–66. 10.1038/ismej.2007.3
    1. Manichanh C, Rigottier-Gois L, Bonnaud E, et al. . Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2006;55:205–11. 10.1136/gut.2005.073817
    1. Qin J, Li Y, Cai Z, et al. . A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012;490:55–60. 10.1038/nature11450
    1. Lindgren M, Löfmark S, Edlund C, et al. . Prolonged impact of a one-week course of clindamycin on Enterococcus spp. in human normal microbiota. Scand J Infect Dis 2009;41:215–9. 10.1080/00365540802651897
    1. Raymond F, Ouameur AA, Déraspe M, et al. . The initial state of the human gut microbiome determines its reshaping by antibiotics. Isme J 2016;10:707–20. 10.1038/ismej.2015.148
    1. Jakobsson HE, Jernberg C, Andersson AF, et al. . Short-Term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS One 2010;5:e9836 10.1371/journal.pone.0009836
    1. Buelow E, Bello González TDJ, Fuentes S, et al. . Comparative gut microbiota and resistome profiling of intensive care patients receiving selective digestive tract decontamination and healthy subjects. Microbiome 2017;5 10.1186/s40168-017-0309-z
    1. Card RM, Mafura M, Hunt T, et al. . Impact of ciprofloxacin and clindamycin administration on gram-negative bacteria isolated from healthy volunteers and characterization of the resistance genes they harbor. Antimicrob Agents Chemother 2015;59:4410–6. 10.1128/AAC.00068-15
    1. Salminen P, Paajanen H, Rautio T, et al. . Antibiotic therapy vs appendectomy for treatment of uncomplicated acute appendicitis: the APPAC randomized clinical trial. JAMA 2015;313:2340–8. 10.1001/jama.2015.6154
    1. Salminen P, Tuominen R, Paajanen H, et al. . Five-Year follow-up of antibiotic therapy for uncomplicated acute appendicitis in the APPAC randomized clinical trial. JAMA 2018;320:1259–65. 10.1001/jama.2018.13201
    1. Sakran JV, Mylonas KS, Gryparis A, et al. . Operation versus antibiotics--The "appendicitis conundrum" continues: A meta-analysis. J Trauma Acute Care Surg 2017;82:1129–37. 10.1097/TA.0000000000001450
    1. Sallinen V, Akl EA, You JJ, et al. . Meta-analysis of antibiotics versus appendicectomy for non-perforated acute appendicitis. Br J Surg 2016;103:656–67. 10.1002/bjs.10147
    1. Podda M, Gerardi C, Cillara N, et al. . Antibiotic treatment and appendectomy for uncomplicated acute appendicitis in adults and children: a systematic review and meta-analysis. Ann Surg 2019. doi:10.1097/SLA.0000000000003225. [Epub ahead of print: 31 Jan 2019].
    1. Harnoss JC, Probst P, Büchler MW, et al. . Antibiotics versus appendicectomy for the treatment of uncomplicated acute appendicitis: an updated meta-analysis of randomised controlled trials by Rollins et al. World J Surg 2017;41:2411 10.1007/s00268-016-3864-8
    1. Rollins KE, Varadhan KK, Neal KR, et al. . Antibiotics versus appendicectomy for the treatment of uncomplicated acute appendicitis: an updated meta-analysis of randomised controlled trials. World J Surg 2016;40:2305–18. 10.1007/s00268-016-3561-7
    1. Chan A-W, Tetzlaff JM, Altman DG, et al. . SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med 2013;158:200–7. 10.7326/0003-4819-158-3-201302050-00583
    1. Haijanen J, Sippola S, Grönroos J, et al. . Optimising the antibiotic treatment of uncomplicated acute appendicitis: a protocol for a multicentre randomised clinical trial (APPAC II trial). BMC Surg 2018;18:117 10.1186/s12893-018-0451-y
    1. Sippola S, Grönroos J, Sallinen V, et al. . A randomised placebo-controlled double-blind multicentre trial comparing antibiotic therapy with placebo in the treatment of uncomplicated acute appendicitis: APPAC III trial study protocol. BMJ Open 2018;8:023623 10.1136/bmjopen-2018-023623
    1. Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 1997;32:920–4. 10.3109/00365529709011203
    1. Vons C, Barry C, Maitre S, et al. . Amoxicillin plus clavulanic acid versus appendicectomy for treatment of acute uncomplicated appendicitis: an open-label, non-inferiority, randomised controlled trial. The Lancet 2011;377:1573–9. 10.1016/S0140-6736(11)60410-8
    1. Sippola S, Grönroos J, Tuominen R, et al. . Economic evaluation of antibiotic therapy versus appendicectomy for the treatment of uncomplicated acute appendicitis from the APPAC randomized clinical trial. Br J Surg 2017;104:1355–61. 10.1002/bjs.10575

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe